How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production and trafficking trends? Be the first to know when the EU drugs agency (EMCDDA) launches its European Drug Report 2020: Trends and Developments in a live online media event on 22 September.
In this latest annual review — marking 25 years of monitoring — the EMCDDA describes the drug situation at the end of 2019, along with recent changes brought by the COVID-19 pandemic in early 2020.
The report (in English) provides a comprehensive analysis of patterns emerging across the EU, Turkey and Norway in the areas of drug supply, illicit drug use and associated public health problems. National data sets are also provided across these themes and on key harm-reduction interventions. In a new format, chapters are organised primarily by drug type and by related harms.
The publication is an essential resource for developing evidence-based policy and action and provides a valuable baseline against which future changes in the drugs field can be measured.
Accompanying the report this year will be a Key Issues summary (in 24 languages), presenting a selection of the main findings from the latest analysis, chosen for their policy relevance and general interest. The 2020 Statistical Bulletin, containing the European dataset underpinning the report, will also be available.
Attend the live online media event to hear the key issues and latest analysis. Journalists will able to put their questions to an EMCDDA panel. The report delivers the most detailed and up-to-date snapshot available of the drug situation in Europe.
Date: 22 September 2020 at 10.00 (Lisbon), 11.00 CET.
Press conference (online):
- Ylva Johansson, European Commissioner for Home Affairs
- Laura d’Arrigo, Chair of the EMCDDA Management Board
- Alexis Goosdeel, EMCDDA Director
Further details will be available in the run-up to the launch at: www.emcdda.europa.eu/edr2020
Media registration: Sign up for the virtual press conference.
Embargoed copies and interviews: firstname.lastname@example.org
Languages: The press conference will be in English, with simultaneous translation available into various languages.
Available in print and PDF